This Tiny Biotech Company's Sales Could Surge 58,213% Thanks to Its Breakthrough Treatment
November 26, 2018 at 16:04 PM EST
A new treatment using "microsphere" technology will completely rewrite the way doctors treat patients for osteoarthritis. Over 30 million Americans alone suffer from this debilitating disease, and no lasting, safe, or reliable drug exists to treat it. Until now... Tags: biotech stocks To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2018 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post This Tiny Biotech Company's Sales Could Surge 58,213% Thanks to Its Breakthrough Treatment appeared first on Money Morning - We Make Investing Profitable .